How severe is CVE-2010-1466?

CVE-2010-1466 has a CVSS 2.0 base score of 6.8, rated medium severity.

Is CVE-2010-1466 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 4% (90th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2010-1466?

CVE-2010-1466 affects Francois Raynaud Openurgence Vaccin. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2010-1466?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2010-1466 published?

CVE-2010-1466 was published on 2010-04-16 and last updated on 2026-06-16.

CVE-2010-1466

CVE-2010-1466 is a medium-severity vulnerability in Francois Raynaud Openurgence Vaccin with a CVSS 2.0 base score of 6.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Severity: Medium (CVSS 2.0 base score 6.8)
EPSS exploit prediction: 4% (90th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-22
Affected product: Francois Raynaud Openurgence Vaccin
Published: 2010-04-16
Last modified: 2026-06-16

Description

Directory traversal vulnerability in scr/soustab.php in openUrgence Vaccin 1.03 allows remote attackers to read arbitrary files via the dsn[phptype] parameter.

Frequently asked questions

What is CVE-2010-1466?: Directory traversal vulnerability in scr/soustab.php in openUrgence Vaccin 1.03 allows remote attackers to read arbitrary files via the dsn[phptype] parameter.
How severe is CVE-2010-1466?: CVE-2010-1466 has a CVSS 2.0 base score of 6.8, rated medium severity.
Is CVE-2010-1466 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 4% (90th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2010-1466?: CVE-2010-1466 affects Francois Raynaud Openurgence Vaccin. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2010-1466?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2010-1466 published?: CVE-2010-1466 was published on 2010-04-16 and last updated on 2026-06-16.

References

Affected products (1)

cpe:2.3:a:francois_raynaud:openurgence_vaccin:1.03:*:*:*:*:*:*:*

More vulnerabilities in Francois Raynaud Openurgence Vaccin

CVE-2010-1467 — High (CVSS 7.5): Multiple PHP remote file inclusion vulnerabilities in openUrgence Vaccin 1.03 allow remote attackers to execute…

All CVEs affecting Francois Raynaud Openurgence Vaccin →

Other CWE-22 (Path Traversal) vulnerabilities

CVE-2026-48282 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted…
CVE-2026-54917 — Critical (CVSS 10.0): SeaweedFS is a distributed storage system for object storage (S3), file systems, and Iceberg tables. Prior to 4.30, the…
CVE-2026-11429 — Critical (CVSS 10.0): Two endpoints in the Vault Service ScriptsController, shared by Altium Enterprise Server and Altium 365, accept file…
CVE-2026-34909 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit a Path Traversal vulnerability found in UniFi OS devices to…
CVE-2026-7411 — Critical (CVSS 10.0): In Eclipse BaSyx Java Server SDK versions prior to 2.0.0-milestone-10, inadequate path normalization in the Submodel…
CVE-2026-36767 — Critical (CVSS 10.0): A path traversal vulnerability in the /content/images/add endpoint of shopizer v3.2.5 allows attackers write arbitrary…

Browse all CWE-22 (Path Traversal) vulnerabilities →